News
Zacks.com on MSN5d
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback